News

May 4, 2022
Arrhythmia mapping technology demonstrates positive clinical results
Bioengineers and cardiologists from UC San Diego invented a technology that can accurately and noninvasively map atrial and ventricular heart arrhythmias in a matter of minutes. The technology demonstrated 97.3 percent accuracy in a clinical validation study, and recently received FDA clearance. Full Story

May 3, 2022
Study of promising Alzheimer's marker in blood prompts warning about brain-boosting supplements
Elevated levels of an enzyme called PHGDH in the blood of older adults could be an early warning sign of Alzheimer's disease. Research led by UC San Diego has consistently found high levels of PHGDH expression in brain tissue and blood samples of older adults with different stages of the disease. The findings also prompt caution against the use of dietary supplements that contain the amino acid serine as a remedy for Alzheimer's disease. Full Story

April 20, 2022
Startup cofounded by UC San Diego bioengineer wins angel investment competition
Karios Technologies, a company cofounded by UC San Diego bioengineering professor Karen Christman, won the inaugural Apis Health Angel Conference, a Seattle-based event that connects investors and health-related startups. Full Story